Experienced in Adenoid Cystic Carcinoma

Florian Sterzing

Kempten (allgaeu), BY, DE 
Experienced in Adenoid Cystic Carcinoma
Kempten (allgaeu), BY, DE 
OverviewLocationsClinical Research

Overview

Florian Sterzing practices in Kempten (allgaeu), Germany. Mr. Sterzing is rated as an Experienced expert by MediFind in the treatment of Adenoid Cystic Carcinoma. His top areas of expertise are Lung Metastases, Prostate Cancer, Anal Cancer, and Adenoid Cystic Carcinoma.

His clinical research consists of co-authoring 88 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Adenoid Cystic Carcinoma.

Gender
Male

Locations

Kempten (allgaeu), BY, Germany
Other Locations
Heidelberg, BW 69120, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prostate and Whole Pelvis Irradiation With Integrated-boost Intensity-modulated Radiotherapy (IMRT) After Neoadjuvant Antihormonal Treatment - a Phase II Trial
Prostate and Whole Pelvis Irradiation With Integrated-boost Intensity-modulated Radiotherapy (IMRT) After Neoadjuvant Antihormonal Treatment - a Phase II Trial
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Radiation
Study Phase: Phase 2
Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial
Evaluation of Inter- and Intrafractional Motion of Liver Tumors Using Interstitial Markers and Implantable Electro-magnetic Radiotransmitters in the Context of Image-guided Radiotherapy (IGRT) - the ESMERALDA Trial
Enrollment Status: Withdrawn
Publish Date: May 17, 2018
Intervention Type: Behavioral
Study Phase: Not Applicable
View 1 Less Clinical Trial

88 Total Publications

Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
Journal: Clinical & experimental metastasis
Published: April 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Sterzing's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile